New research out of UIC suggests racial disparities among those with MPN

March 11, 2016

Researchers from the University of Illinois at Chicago have just published a study that demonstrated a difference between Caucasians and non-Caucasians for those with myeloproliferative neoplasms.

In an analyisis of data spanning over a decade, Dr. Rondelli et al found that Caucasian patients with PV and ET had a higher risk of progression to myelofibrosis, but that Caucasian race emerged as an independent prognostic factor protective against cardiovascular thrombosis in PV and ET patients. Non-Caucasian race was also a significant risk factor for hemorrhagic complications of PV and ET and this was largely driven by African American ethnicity. Click here to read more

Receive updates on the latest MPN news & events.

Find out ways you can help support MPN patients and researchers.



Get free, timely information on living with an MPN.